[Prognostic value of interim and post-therapy 18F-FDG PET-CT in patients with T-cell lymphomas].
Department of Lymphoma, Peking University Cancer Hospital & Institute, Key Laboratory of Ministry of Education of Carcinogenesis and Translational Research, Beijing 100142, China.
Xiaopei
X
Wang
Department of Lymphoma, Peking University Cancer Hospital & Institute, Key Laboratory of Ministry of Education of Carcinogenesis and Translational Research, Beijing 100142, China.
Huiying
H
Huang
Department of Lymphoma, Peking University Cancer Hospital & Institute, Key Laboratory of Ministry of Education of Carcinogenesis and Translational Research, Beijing 100142, China.
Zhitao
Z
Ying
Department of Lymphoma, Peking University Cancer Hospital & Institute, Key Laboratory of Ministry of Education of Carcinogenesis and Translational Research, Beijing 100142, China.
Xuejuan
X
Wang
Department of Lymphoma, Peking University Cancer Hospital & Institute, Key Laboratory of Ministry of Education of Carcinogenesis and Translational Research, Beijing 100142, China.
Yuqin
Y
Song
Department of Lymphoma, Peking University Cancer Hospital & Institute, Key Laboratory of Ministry of Education of Carcinogenesis and Translational Research, Beijing 100142, China.
Wen
W
Zheng
Department of Lymphoma, Peking University Cancer Hospital & Institute, Key Laboratory of Ministry of Education of Carcinogenesis and Translational Research, Beijing 100142, China.
Yan
Y
Xie
Department of Lymphoma, Peking University Cancer Hospital & Institute, Key Laboratory of Ministry of Education of Carcinogenesis and Translational Research, Beijing 100142, China.
Ningjing
N
Lin
Department of Lymphoma, Peking University Cancer Hospital & Institute, Key Laboratory of Ministry of Education of Carcinogenesis and Translational Research, Beijing 100142, China.
Meifeng
M
Tu
Department of Lymphoma, Peking University Cancer Hospital & Institute, Key Laboratory of Ministry of Education of Carcinogenesis and Translational Research, Beijing 100142, China.
Lingyan
L
Ping
Department of Lymphoma, Peking University Cancer Hospital & Institute, Key Laboratory of Ministry of Education of Carcinogenesis and Translational Research, Beijing 100142, China.
Weiping
W
Liu
Department of Lymphoma, Peking University Cancer Hospital & Institute, Key Laboratory of Ministry of Education of Carcinogenesis and Translational Research, Beijing 100142, China.
Lijuan
L
Deng
Department of Lymphoma, Peking University Cancer Hospital & Institute, Key Laboratory of Ministry of Education of Carcinogenesis and Translational Research, Beijing 100142, China.
Chen
C
Zhang
Department of Lymphoma, Peking University Cancer Hospital & Institute, Key Laboratory of Ministry of Education of Carcinogenesis and Translational Research, Beijing 100142, China.
Zhi
Z
Yang
Department of Lymphoma, Peking University Cancer Hospital & Institute, Key Laboratory of Ministry of Education of Carcinogenesis and Translational Research, Beijing 100142, China.
Jun
J
Zhu
D000328:Adult; D000368:Aged; D018572:Disease-Free Survival; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D016399:Lymphoma, T-Cell / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D049268:Positron-Emission Tomography; D011379:Prognosis
D019788:Fluorodeoxyglucose F18